Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Janagliflozin plus metformin in Chinese adults with type 2 diabetes inadequately controlled on metformin
CTR20190513Phase 3Completed
- Sponsor
- Xuanzhu Biopharmaceutical
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of janagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Xuanzhu Biopharmaceutical. Started Apr 2019; status: completed.
02
Drugs
janagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20190513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190513.